F-18 FDG PET 在胃淋巴上皮瘤样癌中的临床价值
回顾性纳入28例术前接受F-18 FDG PET/CT的胃淋巴上皮瘤样癌患者,PET/CT对进展期胃癌检出率85.0%(17/20)、早期胃癌12.5%(1/8),淋巴结转移灵敏度47.8%、特异度100.0%,随访9例中检出3例恶性病变,作者认为PET/CT可能有助于评估远处转移或复发。
要点
- PET/CT对胃淋巴上皮瘤样癌早期胃癌检出率仅12.5%(1/8),进展期胃癌为85.0%(17/20)。
- 淋巴结转移灵敏度47.8%(11/23)、特异度100.0%(13/13),远处转移或第二原发恶性肿瘤特异度96.3%。
- 复发或第二原发恶性肿瘤检测灵敏度100%、特异度100%,但仅9例接受随访PET/CT。
核心结论
- F-18 FDG PET/CT可能是评估胃淋巴上皮瘤样癌患者远处转移或复发的有用工具。
研究设计与样本
- 回顾性研究,纳入28例术前接受F-18 FDG PET/CT的胃淋巴上皮瘤样癌患者(平均年龄59岁),其中9例接受随访F-18 FDG PET/CT;通过胃切除术获取病理信息,26例检测EB病毒(EBV)关联。
关键影像表现/征象
- PET/CT检出85.0%(17/20)的进展期胃癌和12.5%(1/8)的早期胃癌。
- 大多数肿瘤(23/26,88.5%)与EBV相关。
- FDG高摄取肿瘤的最大标准化摄取值(SUVmax)为7.5±3.0。
- PET/CT另检出1例患者肝脏肉瘤样癌。
诊断标准与关键数值
- PET/CT检测淋巴结转移的灵敏度47.8%(11/23)、特异度100.0%(13/13)。
- PET/CT检测远处转移或第二原发恶性肿瘤的特异度96.3%。
- 随访PET/CT检测复发或第二原发恶性肿瘤的灵敏度100%、特异度100%(9例中检出3例恶性病变:1例肝转移、复发性肝脏肉瘤样癌和异时性胆管癌;其余6例正确排除复发)。
临床应用与阅片要点
- 作者认为F-18 FDG PET/CT可能是评估胃淋巴上皮瘤样癌患者远处转移或复发的有用工具。
- 原文未据此给出关于早期胃癌检出或淋巴结分期的具体阅片建议。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Lymphoepithelioma-like carcinoma (LELC) is a rare type of gastric cancer. We evaluated the clinical usefulness of F-18 FDG positron emission tomography/computed tomography (PET/CT) in LELC of stomach.
MATERIALS AND METHODS: A total of 28 patients (mean age=59years) who underwent preoperative F-18 FDG PET/CT were enrolled retrospectively. Nine patients underwent follow-up F-18 FDG PET/CT. Pathologic information was obtained through gastrectomy and the association with Epstein-Barr virus (EBV) was investigated in 26 patients.
RESULTS: PET/CT detected 85.0% (17/20) of advanced gastric cancers (AGC) and 12.5% (1/8) of early gastric cancers (EGC). Most tumors (23/26, 88.5%) were EBV-associated. The maximum standardized uptake value of FDG-avid tumors was 7.5±3.0. The sensitivity and specificity of PET/CT for the presence of lymph node metastasis was 47.8% (11/23) and 100.0% (13/13), respectively. PET/CT also detected a hepatic sarcomatoid carcinoma in one patient. The specificity of PET/CT for distant metastasis or second malignancy was 96.3%. Follow-up PET/CT detected malignant lesions in 3 of 9 patients; a liver metastasis, recurrent hepatic sarcomatoid carcinomas and a metachronous cholangiocarcinoma. PET/CT correctly excluded recurrence in the rest of the patients (6/6). The sensitivity and specificity of PET/CT for detecting recurrence or second malignancy was 100% and 100%, respectively.
CONCLUSION: F-18 FDG PET/CT would be a useful tool in evaluating distant metastasis or recurrence in patients with gastric LELC.
引用
- Park S, Lee D, Lee KM, et al. Clinical usefulness of F-18 FDG PET in lymphoepithelioma-like gastric carcinoma. Eur J Radiol. 2017. PMID: 28712702. doi:10.1016/j.ejrad.2017.06.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。